| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
Department of Animal Science, University of California, Davis, Davis, California 95616, USA and 1 Animal and Veterinary Science, University of Maine, Orono, Maine 04469, USA
Correspondence should be addressed to G B Anderson; Email: gbanderson{at}ucdavis.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
PL lactogen is a member of the growth hormone (GH)/prolactin (PRL) gene family synthesized and stored in secretory granules of the trophoblast BCs (Byatt et al. 1992a, Wooding 1992, Gootwine 2004). Although its function and secretory control are not completely understood, in vivo and in vitro studies have suggested PL to have multiple somatogenic (GH-like) and lactogenic (PRL-like) biological effects, depending on the species, such as placental angiogenesis, maternal and foetal intermediate metabolism, mammary gland development and function, ovarian and placental steroidogenesis, growth rate and luteal function (Patel et al. 1996, Pedersen et al. 1998, Gregoraszczuk et al. 2000, Corbacho et al. 2002, Gertler & Djiane 2002, Gootwine 2004). Bovine (b) PL is more structurally similar to PRL than GH and is secreted into both the maternal and foetal systems (Gootwine 2004), with a decrease in foetal concentrations during the course of gestation and a peak in maternal plasma during the last trimester of pregnancy (Byatt et al. 1992a). It has been postulated that bPL recognizes homologous and heterologous somatogenic and lactogenic receptors, acting through components of the insulin-like growth factor system, which may modulate foetal growth (Byatt et al. 1992a, Anthony et al. 1995).
PSPB was first isolated from bovine placental tissues, as a product of the BCs of the trophoblastic ectoderm (Butler et al. 1982). Several isoforms of pregnancy-associated glycoproteins (PAG) from foetal cotyledons showing similarities with PSPB have been isolated (Zoli et al. 1991). Currently, PSPB is also known as PAG-1, being inactive members of the aspartic proteinase family (Xie et al. 1991, Lynch et al. 1992). Gene and cDNA sequencing have shown identical homology between PSPB and PAG-1, with both proteins differing only in glycosylation and sialic acid contents (Xie et al. 1991, 1995, Lynch et al. 1992). Concentrations of bPSPB in maternal plasma can be detected from early stages of gestation, during early placentation, to increase gradually throughout pregnancy and reach peak values immediately before parturition (Sasser et al. 1986, Kiracofe et al. 1993). Despite the unknown function and control of PSPB secretion, many potential biological functions have been suggested based on in vivo and in vitro effects, including prostaglandin release by the endometrium, implantation, immunotolerance of the conceptus as a tissue alograft and uterine remodelling after parturition, among others (Del Vecchio et al. 1990, 1995, 1996, Kiracofe et al. 1993, Austin et al. 1999, Tefera et al. 2001). Both PAG-1 and PSPB diagnostic assays have been developed for early plasma diagnosis of pregnancy in cattle and other ruminants (Sasser et al. 1986, Zoli et al. 1991, Green et al. 2000).
The amounts of BC products in maternal circulation appear to be associated with placental mass, foetal number and neonatal birth weight, and have been postulated to be an index for conceptus viability and pregnancy normalcy in cattle (Byatt et al. 1992a, Patel et al. 1995, 1996, 1997, Vasquez et al. 1995, Szenci et al. 1998, 2003, Tefera et al. 2001, Ravelich et al. 2004). Associations between abnormal placental and foetal development after in vitro embryo manipulations have been suggested to play a key role in the occurrence of high birth weights. Disturbances in placentation may at least partially affect the pattern of foetal growth (Hill et al. 2000, 2001, Bertolini et al. 2002a, Hashizume et al. 2002, Reik et al. 2003). Disruptions in BC function may compromise the viability and growth of the developing conceptus. Since significant spatial and temporal differences in the expression in the more than 20 identified bPAG cDNA isoforms appear to occur during bovine pregnancy (Green et al. 2000), distinct isoforms of the PAG-1 group may be more useful for the diagnosis of pregnancy and to predict deviations from normality. This study describes results using the same animals and samples as in previous reports (Bertolini et al. 2002a,b, 2004) to further investigate bovine foetal and placental development and their association with placental transcripts (bPL and bPAG-1) and plasma and foetal fluid protein concentrations (bPL and bPSPB) in in vivo-produced and in vitro-produced (IVP) concepti and newborn calves for use as potential biological markers for altered conceptus development after in vitro embryo manipulations.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Embryo production, embryo transfer and pregnancy diagnosis
IVP and in vivo-produced (controls) Bos taurus embryos were generated according to our established procedures, as previously described (Bertolini et al. 2002a,b, 2004). We have adopted an IVP system known to induce, at a relatively high frequency, the appearance of symptoms of the Large Calf Syndrome (Behboodi et al. 1995, Bertolini et al. 2002a, 2004). Bovine cumulus–oocyte complexes from Angus–Hereford cross females were obtained either from a commercial source (Bomed Inc., Madison, WI, USA) or from a regional slaughterhouse. Donor females (Angus or Angus–Hereford crosses) were superovulated for the production of control embryos. Embryos were non-surgically recovered by uterine flushing on day 7 of development (artificial insemination = day 0). The same Angus sires were used for production of both control and IVP embryos. Blastocysts and expanded blastocysts from both embryo production systems (control and IVP) were non-surgically transferred to synchronous (±12 h) recipients on day 7 of development. Single embryos were transferred to recipients for the group of animals slaughtered on days 90 and 180, whereas one (in vivo singleton, in vitro singleton) or two (in vitro twin) embryos were transferred for the group of females allowed to carry pregnancies to term (Bertolini et al. 2002a, 2004). Pregnancy and foetal gender diagnoses were carried out by means of ultrasonography, per rectum, on days 27–30 and 58–60 of gestation respectively (Bertolini et al. 2002a, 2004).
Conceptus development and sample collection
Detailed morphometric, morphological and physiological data regarding foetal and placental development during pregnancy and after delivery for the group of recipients slaughtered on days 90 and 180 or allowed to carry pregnancies to term have been described previously (Bertolini et al. 2002a, 2004).
Days 90 and 180 of gestation
A group of pregnant females was slaughtered on days 90 or 180 of gestation (n = 4 in control and n = 5 IVP pregnancies for each day) for the collection of pregnant uteri and their respective foetuses and placental membranes. Pregnant females were allocated to each harvest day according to foetal gender and foetal viability after ultrasound examinations. In the control group (n = 8), animals carrying three females and one male were assigned to each harvest day (90 and 180) and, in the IVP group (n = 10), female recipients sustaining pregnancies with four females and one male were harvested on day 90, and recipients carrying three females and two males on day 180 of gestation. Foetal gender diagnoses performed on day 60 of pregnancy were all confirmed after harvest. Upon slaughter, reproductive tracts were excised and immediately weighed. Maternal blood samples were obtained at exsanguination. Following uterine dissection, foetal blood was collected by cardiopuncture, and total allantoic and amniotic fluid volumes were measured and sampled. Maternal and foetal blood, and amniotic and allantoic fluids were centrifuged, and plasma and fluids were frozen and stored at –80 °C pending analyses. Individual placentomes were weighed and measured (length and width) for estimation of the total gross surface area (SA). Placentomes were also classified into four categories by type according to gross morphological appearance, as follows: (A) engulfing mushroom-like, (B) sub-engulfing mushroom-like, (C) flattened, non-engulfing and (D) semi-convex placentomes (Fig. 1a
). Sample placentomes from the region immediately surrounding the foetuses were excised along their longitudinal axis, and pieces containing both maternal and foetal boundaries were snap-frozen in liquid nitrogen, stored at –80 °C and ultimately used for measurement of the relative transcription of genes of placental products (bPL and bPAG-1), as described below.
|
bPL and pPSPB measurements in plasma and foetal fluids
Concentrations of bPL and bPSPB were determined by radioimmunoassay, in duplicates of maternal, foetal and neonatal plasma, and amniotic and allantoic fluids, according to established procedures by Wallace (1993) for bPL and Sasser et al.(1986) for bPSPB (BioTracking, Moscow, ID, USA). In this study, intra- and interassay coefficients of variation were 4.9% and 12.0% for bPL and 10.2% and 15.7% for bPSPB respectively.
Relative abundance of bPL and bPAG-1 transcripts in day-90 and -180 placentomes
A real-time TaqMan PCR (Applied Biosystems, Foster City, CA, USA) was optimized to quantify transcripts for bPL and bPAG-1 genes, following procedures described by Bertolini et al. (2002b, 2004). The analysis was performed at the Lucy Whittier Molecular Core Facility, School of Veterinary Medicine, University of California, Davis. Quantitative analyses of bovine cDNA from control and IVP day-90 and day-180 placentomes were performed in comparison with the endogenous control (glyceraldehyde-3-phosphate dehydrogenase; GAPDH), and were amplified in an automated laser-based fluorometer (7700 ABI PRISM Sequence Detection System; Applied Biosystems). Final quantification was done using the comparative CT method (Leutenegger et al. 2000). All samples were included in each assay, in single reactions, with one assay per transcript. Sequences of primers and probes for the transcripts are shown in Table 1.
|
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Data regarding the comparison of physical traits between in vivo- and in vitro-derived concepti, newborn calves and term foetal membranes have been described previously (Bertolini et al. 2002a, 2004) and are summarized in Table 2. Placentomes were longer, wider and thinner (Fig. 1b
) in the IVP group (Bertolini et al. 2004), and distribution of placentome types was also different between groups (P < 0.05) on day 180 of pregnancy, with the occurrence of more uncommon types (C and D) in IVP pregnancies (Fig. 1c). The presence of such types, primarily type C, in controls was usually associated with small placentomes located in the nonfoetal horn, whereas these placentome types were randomly present in both uterine horns of IVP pregnancies in a wide size range. The difference in individual placentome size in the IVP group on day 90 of gestation, particularly in the foetal horn, was correlated with significantly higher (P < 0.05) concentrations of bPL and bPSPB in foetal plasma and allantoic fluid, and relative abundance of placentome transcripts for bPL and bPAG-1 in IVP concepti (Fig. 2a and b). On day 180, the relative abundance of placental transcripts for bPL and bPAG-1 (Fig. 2a and b) and uterine, foetal and placental physical component weights (Bertolini et al. 2004, Table 2) were larger in IVP pregnancies than in controls. Concentrations of bPSPB in the allantoic fluid of IVP pregnancies were 2.9-fold lower than controls (Fig. 2b) but, since day-180 IVP pregnancies had a 2- to 3-fold larger allantoic fluid volume than controls (Bertolini et al. 2004), total bPL and bPSPB in the allantois were higher and similar to controls respectively (Fig. 2c).
|
|
. Temporally, concentrations of bPL were higher in the uterine compartments (foetal plasma and fluids) than in maternal plasma, apart from the experimental group (Pday < 0.05). In addition, maternal concentrations of bPL and bPSPB were higher on day 180 than on day 90 (Pday < 0.05), but lower in foetal plasma (bPL and bPSPB) and amniotic fluid (bPL). Positive correlations were observed between bPL and bPAG-1 transcripts (r = 0.824, P < 0.05), between bPL and bPSPB concentrations in the same fluid type (maternal plasma, r = 0.715, foetal plasma, r = 0.635, amniotic fluid, r = 0.505, P < 0.05, except in allantoic fluid), and between maternal concentrations of bPL and bPSPB (r > 0.850, P < 0.05), and with glucose and fructose accumulations (r > 0.650, P < 0.05) in the uterine compartments (data not shown, Bertolini et al. 2004). Positive correlations were observed also between conceptus component weights, substrate (glucose and fructose, data not shown) accumulations and bPAG-1 transcripts (r > 0.600, P < 0.05).
Plasma concentrations of bPL throughout gestation in pregnant females carrying in vivo singleton, in vitro singleton and in vitro twin concepti are illustrated in Fig. 3. Three distinct phases can be visualized in the weeks preceding parturition, based on the variation in bPL concentrations among groups (Fig. 3). In phase I (weeks 39 and 24 prepartum), no differences in concentrations of maternal plasma bPL were observed between groups. Then, in phase II (week 23 to week 8–9 prepartum), concentrations of maternal bPL were significantly higher in the in vitro twin group (P < 0.05). In phase III (week 8–9 to week 1 prepartum), maternal concentrations in the in vitro singleton group were lower (P < 0.05), but similar to controls and the in vitro twin group as parturition approached. At delivery, concentrations of maternal plasma bPL were significantly different between groups (in vivo singletons < in vitro singletons < in vitro twins, P < 0.05), to become similar 24 h after parturition.
|
, for a steady increase in plasma concentrations from early to late pregnancy, with a decline following parturition. The in vitro singleton group had lower bPSPB concentrations than controls and the in vitro twin group in the week and the day immediately preceding and following parturition respectively (P < 0.05), but no other significant differences were observed between groups at any further stage of gestation examined.
|
). Plasma concentrations of bPSPB tended to be higher (P < 0.08) and became significantly higher (P < 0.05) in the in vitro singleton group 60 min and 24 h after birth respectively (Fig. 5b). Concentrations of bPL and bPSPB in the first 60 min postpartum were positively correlated with neonatal and foetal membrane physical traits (r > 0.800, P < 0.05), and correlated with neonatal plasma fructose concentrations (data not shown, Bertolini et al. 2004).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
In this study, placental and foetal membrane weight and placental and cotyledonary SAs were greater in IVP pregnancies, and both mass and SAs increased as a function of the increase in placentome length and width, but placentomes were thinner at both days 90 and 180 of gestation. Changes in placental morphology and deviations in the morphological distribution of the placentome type (fewer types A and B and increased unusual C and D types) were readily detectable in the first and second trimester of gestation in IVP pregnancies (Fig. 1). Such variations in placentome types may reflect anatomical, histological and functional differences in development, and such changes may ultimately influence placental transport efficiency, function, metabolism and synthetic capacity. Under physiological conditions, the placenta grows faster than the foetus in early pregnancy but slower after mid-gestation, when foetal weight surpasses that of the placenta (Eley et al. 1978, Prior & Laster 1979, Reynolds et al. 1990). Morphologically, the bovine placenta is considered fully developed at mid- to late gestation, but foetal villous trees continue to develop (branching pattern) and rearrange (spatial relationship between endothelium and trophoblast) in placentomes until near term, increasing the villous SA, which will also accommodate foetal demands for growth towards the end of gestation (Leiser et al. 1997). However, the placental tissue holds a great plastic capacity in facing unusual, adverse circumstances. Maternal dietary restriction or hypoxia in early gestation in cattle and sheep can initially impair such a standard pattern of placental growth (Penninga & Longo 1998, Perry et al. 1999, Wallace et al. 1999, Symonds et al. 2001) but, once dietary intake is restored to normal, a placental and foetal growth compensatory enhancement is observed. A coincidental aspect of these findings with our studies is that IVP concepti were significantly smaller during the period of placentation to the early foetal stage (up to day 58 of gestation), which appeared to have preceded a subsequent compensatory growth initiated with the placental tissue and followed by the foetus (Bertolini et al. 2002a). A hormonal effect of PSPB has been demonstrated in inducing the in vitro release of an 
chemokine (granulocyte chemotactic protein-2) by the endometrium, which may be relevant for implantation and placental angiogenesis (Austin et al. 1999). Bovine placental PAG-1 and foetal plasma PSPB were elevated in the IVP group at a time at which placental compensatory growth was already detectable (day 90).
The amounts of placental products in maternal circulation appear to be associated with placental and foetal masses, including foetal number and neonatal birth weight, and with pregnancy normalcy (Byatt et al. 1992a, Patel et al. 1995, 1997, Vasquez et al. 1995, Tefera et al. 2001, Gootwine 2004). In this study, concentrations of maternal and foetal plasma bPL followed similar trends reported by Hossner et al.(1997), Holland et al.(1997) and Patel et al.(1996), but concentrations of bPL and bPSPB in foetal plasma were correlated with conceptus physical traits and with one another in plasma and fluids. Anthony et al.(1995) suggested that a relationship exists between ovine PL gene expression and the rate of ovine PL appearance in foetal circulation, an observation that appears to be valid for our findings with both bPL and bPSPB. Increased bPL and bPSPB relative mRNA abundances in day-90 and day-180 placentomes and concentrations in the foetal plasma and allantoic fluid on day 90, along with accumulations of glucose and fructose in foetal plasma and associated fluids (Bertolini et al. 2004), were associated with an increase in prenanatal growth and foetal number in IVP concepti. As placentomes from IVP pregnancies were distinct from controls in terms of morphology, mass and surface area, the pattern of secretion of BC products may have been affected and explain some of the distinct patterns seen in IVP pregnancies.
The elevation in bPL in the third trimester of pregnancy coincides with the period of faster foetal growth and mammogenesis (Patel et al. 1996). In fact, newborn IVP calves coincidentally displayed higher birth weights and plasma bPL and fructose concentrations immediately after birth (Bertolini et al. 2002a, 2004). Conversely, maternal concentrations of bPL during phase III of pregnancy (Fig. 3) in the in vitro singleton group were lower than in vitro twin and in vivo singleton groups and, at parturition, maternal bPL concentrations in in vivo-produced pregnancies fell earlier than in those that were in vitro derived (Fig. 3). Interestingly, Miles et al.(2004) reported a reduction in foetal villi and BC volume densities in day-222 IVF-derived placentomes, which coincides with the period of decrease in maternal bPL levels in females carrying IVP singleton foetuses in this study.
Evidence exists that protein expression in BCs is affected by anatomical location (Wooding et al. 1996, Patel et al. 2004b), and such differences in synthetic capacity appear to be more under maternal than foetal influence, since both cotyledonary and intercotyledonary tissues are exposed to a similar foetal environment (Wooding et al. 1996). The presence of higher concentrations of bPL in IVP calves in the first hour after birth, along with higher concentrations in the allantoic fluid, suggests that a ‘leakage’ occurs from placental tissue to the foetal circulation, since no or negligible transfer of PL appears to occur from the maternal to the foetal circulation in sheep (Reddy & Watkins 1983). Such findings corroborate the concept that the pattern of secretion of bPL in the foetal circulation may be relevant for foetal growth (Byatt et al. 1992a) and disturbances in placental formation may lead to such differential pattern of bPL secretion between the maternal and uterine compartments (Ravelich et al. 2004).
In addition to placental mass, parity and nutrition also appear to modulate the secretion of bPL. However, Patel et al.(1996) did not find distinctions in maternal bPL concentrations between singleton- and twin-bearing pregnancies, which the authors explained as a reduced placental mass per foetus in twin-bearing pregnancies. For singleton-bearing pregnancies, a relationship exists between placental and neonatal birth weights and maternal bPL concentrations, which could be used as a marker for conceptus development, viability and predicting abnormal birth weights (Patel et al. 1996). The half-life for the recombinant bPL has been reported to be 7.5 min (Byatt et al. 1992b), which is shorter than for GH or PRL but, as native bPL is heavily glycosylated (Byatt et al. 1992a), a half-life similar to GH and PRL (20 to 30 min) is expected, which is visible in plasma of newborn calves in the first 60 min following birth (Fig. 5a). Conversely, as bPSPB has a rather long half-life, with its plasma levels still detectable 3 months or more after parturition (Sasser et al. 1986, Kiracofe et al. 1993), neonatal plasma concentrations remained elevated throughout the period under scrutiny (24 h) following parturition (Fig. 5b). However, differences in plasma clearance perhaps highlight bPL as a more dependable marker for pregnancy normalcy than bPSPB.
Many of the changes in placental development and function in the IVP group in this study were associated with the accelerated pattern of foetal growth, the delivery of larger calves, and the appearance of aberrant foetal membranes at term, and an increase in substrate uptake and protein synthetic capacity in IVP pregnancies (Bertolini et al. 2002a, 2004). Concentrations of bPL and bPSPB in foetal plasma were correlated with physical traits and with one another in foetal plasma and associated fluids irrespective of the experimental groups. Differential patterns of secretion of bPL and bPSPB into the maternal and foetal systems occurred at distinct stages of gestation, which were associated with altered conceptus development after in vitro embryo manipulations, indirectly demonstrating differences in placental function in IVP pregnancies. However, bPSPB/bPL prenatal measurements in foetal plasma and fluids were useful indicators of abnormal growth and development, but such invasive measurements lack a practical application.
|
Acknowledgements |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
|
Footnotes |
|---|
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Anthony RV, Pratt SL, Liang R & Holland MD 1995 Placental-fetal interactions: impact on fetal growth. Journal of Animal Science 73 1861–1871.[Abstract]
Austin KJ, King CP, Vierk JE, Sasser RG & Hansen TR 1999 Pregnancy-specific protein B induces release of an alpha chemokine in bovine endometrium. Endocrinology 140 542–545.
Behboodi E, Anderson GB, BonDurant RH, Cargill SL, Kreuscher BR, Medrano JF & Murray JD 1995 Birth of large calves that developed from in vitro-derived bovine embryos. Theriogenology 44 227–232.
Bertolini M, Mason JB, Beam SW, Carneiro GF, Sween ML, Moyer AL, Famula TR, Sainz RD & Anderson GB 2002a Morphology and morphometry of in vivo- and in vitro-produced bovine concepti from early pregnancy to term and association with high birth weights. Theriogenology 58 973–994.[CrossRef][Web of Science][Medline]
Bertolini M, Beam SW, Shim H, Bertolini LR, Moyer AL, Famula TR & Anderson GB 2002b Growth, development and gene expression by in vivo- and in vitro-produced day-7 and day-16 bovine embryos. Molecular Reproduction and Development 63 318–328.[CrossRef][Web of Science][Medline]
Bertolini M, Moyer AL, Mason JB, Batchelder CA, Hoffert KA, Bertolini LR, Carneiro GF, Cargill SL, Famula TR, Calvert CC, Sainz RD & Anderson GB 2004 Evidence of increased substrate availability to in vitro-derived bovine foetuses and association with accelerated conceptus growth. Reproduction 128 341–354.
Butler JE, Hamilton WC, Sasser RG, Ruder CA, Hass GM & Williams RJ 1982 Detection and partial characterization of two bovine pregnancy-specific proteins. Biology of Reproduction 26 925–933.[Abstract]
Byatt JC, Warren WC, Eppard PJ, Staten NR, Krivi GG & Collier RJ 1992a Ruminant placental lactogens: structure and biology. Journal of Animal Science 70 2911–2923.[Abstract]
Byatt JC, Eppard PJ, Veenhuizen JJ, Sorbet RH, Buonomo FC, Curran DF & Collier RJ 1992b Serum half-life and in vivo actions of recombinant bovine placental lactogen in the dairy cow. Journal of Endocrinology 132 185–193.
Corbacho AM, Martinez De La Escalera G & Clapp C 2002 Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. Journal of Endocrinology 173 219–238.[Abstract]
Del Vecchio RP, Sasser RG & Randel RD 1990 Effect of pregnancy-specific protein B on prostaglandin F2 and prostaglandin E2 by day 16-perifused bovine endometrial tissue. Prostaglandin 40 271–282.[CrossRef][Web of Science][Medline]
Del Vecchio RP, Sutherland WD & Sasser RG 1995 Effect of pregnancy-specific protein B on luteal cell progesterone, prostaglandin, and oxytocin production during two stages of the estrous cycle. Journal of Animal Science 73 2662–2668.[Abstract]
Del Vecchio RP, Sutherland WD & Sasser RG 1996 Bovine luteal cells production in vitro of prostaglandin E2, oxytocin and progesterone in response to pregnancy-specific protein B and prostaglandin F2 alpha. Journal of Reproduction and Fertility 107 131–136.
Eiler H & Hopkins FM 1993 Successful treatment of retained placenta with umbilical cord injections of collagenase in cows. Journal of the American Veterinary Medical Association 203 436–443.[Web of Science][Medline]
Eley RM, Thatcher WW, Bazer FW, Wilcox CJ, Becker RB, Head HH & Adkinson RW 1978 Development of the conceptus in the bovine. Journal of Dairy Science 61 467–473.
Gertler A & Djiane J 2002 Mechanism of ruminant placental lactogen action: molecular and in vivo studies. Molecular Genetics and Metabolism 75 189–201.[CrossRef][Web of Science][Medline]
Green JA, Xie S, Quan X, Bao B, Gan X, Mathialagan N, Beckers JF & Roberts RM 2000 Pregnancy-associated bovine and ovine glycoproteins exhibit spatially and temporally distinct expression patterns during pregnancy. Biology of Reproduction 62 1624–1631.
Gootwine E 2004 Placental hormones and fetal-placental development. Animal Reproduction Science 82–83 551–566.
Gregoraszczuk EL, Zieba D, Wierzchos, Murawski M & Gertler A 2000 Placental lactogen as a regulator of luteal function during pregnancy in sheep. Theriogenology 53 877–885.[CrossRef][Web of Science][Medline]
Hashizume K, Ishiwata H, Kizaki K, Yamada O, Takahashi T, Imai K, Patel OV, Akagi S, Shimizu M, Takahashi S, Katsuma S, Shiojima S, Hirasawa A, Tsujimoto G, Todoroki J & Izaike Y 2002 Implantation and placental development in somatic cell clone recipient cows. Cloning and Stem Cells 4 197–209.[CrossRef][Medline]
Heyman Y, Chavette-Palmer, LeBourhis D, Camous S, Vignon X & Renard JP 2002 Frequency and occurrence of late-gestation losses from cattle cloned embryos. Biology of Reproduction 66 6–13.
Hill JR, Burghardt RC, Jones K, Long CR, Looney CR, Shin T, Spencer TE, Thompson JA, Winger QA & Westhusin ME 2000 Evidence for placental abnormality as the major cause of mortality in first-trimester somatic cell cloned bovine fetuses. Biology of Reproduction 63 1787–1794.
Hill JR, Edwards JF, Sawyer N, Blackwell C & Cibelli JB 2001 Placental anomalies in a viable cloned calf. Cloning 3 83–88.[CrossRef][Medline]
Hoffert KA, Batchelder CA, Bertolini M, Moyer AL & Anderson GB 2004 Angiogenesis in cloned and in IVF-derived bovine pregnancies at day 30 of gestation. Reproduction Fertility and Development 16 143 (Abstract).
Holland MD, Hossner KL, Williams SE, Wallace CR, Niswender GD & Odde KG 1997 Serum concentrations of insulin-like growth factors and placental lactogen during gestation in cattle. I. Fetal profiles. Domestic Animal Endocrinology 14 231–239.[CrossRef][Web of Science][Medline]
Hossner KL, Holland MD, Williams SE, Wallace CR, Niswender GD & Odde KG 1997 Serum concentrations of insulin-like growth factors and placental lactogen during gestation in cattle. II. Maternal profiles. Domestic Animal Endocrinology 14 316–324.[CrossRef][Web of Science][Medline]
Ishiwata H, Katsuma S, Kizaki K, Patel OV, Nakano H, Takahashi T, Imai K, Hirasawa A, Shiojima S, Ikawa H, Suzuki Y, Tsujimoto G, Izaike Y, Todoroki J & Hashizume K 2003 Characterization of gene expression profiles in early bovine pregnancy using a custom cDNA microarray. Molecular Reproduction and Development 65 9–18.[CrossRef][Web of Science][Medline]
Kiracofe GH, Wright JM, Schalles RR, Ruder CA, Parish S & Sasser RG 1993 Pregnancy-specific protein B in serum of postpartum beef cows. Journal of Animal Science 71 2199–2205.[Abstract]
Laven RA & Peters AR 2001 Gross morphometry of the bovine placentome during gestation. Reproduction in Domestic Animals 36 289–296.[CrossRef][Web of Science][Medline]
Leiser R, Krebs C, Klisch K, Ebert B, Dantzer V, Schuler G & Hoffmann B 1997 Fetal villosity and microvasculature of the bovine placentome in the second half of gestation. Journal of Anatomy 191 517–527.
Leutenegger CM, Alluwaimi AM, Smith WL, Perani L & Cullor JS 2000 Quantitation of bovine cytokine mRNA in milk cells of healthy cattle by real-time TaqMan® polymerase chain reaction. Veterinary Immunology and Immunopathology 77 275–387.[CrossRef][Web of Science][Medline]
Lynch RA, Alexander BM & Sasser RG 1992 The cloning and expression of the pregnancy-specific protein B. Biology of Reproduction 46 (Suppl 1) 72 (Abstract).[CrossRef]
Miles JR, Farin CE, Rodriguez KF, Alexander JE & Farin PW 2004 Angiogenesis and morphometry of bovine placentas in late gestation from embryos produced in vivo or in vitro. Biology of Reproduction 71 1919–1926.
Patel OV, Domeki I, Sasaki N, Takahashi T, Hirako M, Sasser RGU & Humblot P 1995 Effect of mass. number and stage of gestation on pregnancy-specific protein B concentrations in the bovine. Theriogenology 44 827–833.
Patel OV, Hirako M, Takahashi T, Sasaki N & Domeki I 1996 Plasma bovine placental lactogen concentration throughout pregnancy in the cow; relationship to stage of pregnancy, fetal mass, number and postpartum milk yield. Domestic Animal Endocrinology 13 351–359.[CrossRef][Web of Science][Medline]
Patel OV, Sulon J, Beckers JF, Takahashi T, Hirako M, Sasaki N & Domeki I 1997 Plasma bovine pregnancy-associated glycoprotein concentrations throughout gestation in relationship to fetal number in the cow. European Journal of Endocrinology 137 423–428.[Abstract]
Patel OV, Yamada O, Kisaki K, Takahashi T, Imai K, Izaike Y, Schul LA, Takezawa T & Hashizume K 2004a Expression of trophoblast cell-specific pregnancy-related genes in somatic cell-cloned bovine pregnancies. Biology of Reproduction 70 1114–1120.
Patel OV, Yamada O, Kizaki K, Todoroki J, Takahashi T, Imai K, Schuler LA & Hashizume K 2004b Temporospatial expression of placental lactogen and prolactin-related protein-1 genes in the bovine placenta and uterus during pregnancy. Molecular Reproduction and Development 69 146–152.[CrossRef][Web of Science][Medline]
Pedersen JF, Sorensen S & Molsted-Pedersen L 1998 Serum levels of human placental lactogen, pregnancy-associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancy. Acta Obstetricia et Gynecologica Scandinavica 77 155–158.[CrossRef][Web of Science][Medline]
Penninga L & Longo LD 1998 Ovine placentome morphology: effect of high altitude, long-term hypoxia. Placenta 19 187–193.[CrossRef][Web of Science][Medline]
Perry VEA, Norman ST, Owen JA, Daniel RCW & Phillips N 1999 Low dietary protein during early pregnancy alters bovine placental development. Animal Reproduction Science 55 13–21.[CrossRef][Web of Science][Medline]
Prior RL & Laster DB 1979 Development of the bovine fetus. Journal of Animal Science 48 1546–1553.
Ravelich SR, Shelling AN, Ramachandran A, Reddy S, Keelan JA, Wells DN, Peterson AJ, Lee RS & Breier BH 2004 Altered placental lactogen and leptin expression in placentomes from bovine nuclear transfer pregnancies. Biology of Reproduction 71 1862–1869.
Reddy S & Watkins WB 1983 Plasma clearance distribution of 125I-ovine placental lactogen in sheep. Australian Journal of Experimental Biology and Medical Science 61 301–311.[CrossRef][Web of Science]
Reik W, Constancia M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, Tycko B & Sibley C 2003 Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. Journal of Physiology 547 35–44.
Reynolds LP, Ferrell CL, Robertson DA & Klindt J 1990 Growth hormone, insulin and glucose concentrations in bovine fetal and maternal plasmas at several stages of gestation. Journal of Animal Science 68 725–733.[Abstract]
Sasser RG, Ruder CA, Ivani KA, Butler JE & Hamilton WC 1986 Detection of pregnancy by radioimmunoassay of a novel pregnancy-specific protein in serum of cows and a profile of serum concentrations during gestation. Biology of Reproduction 35 936–942.[Abstract]
Schlafer DH, Fisher PJ & Davies CJ 2000 The bovine placenta before and after birth: placental development and function in health and disease. Animal Reproduction Science 60–61 145–160.
Schmidt M, Greve T, Avery B, Beckers JF, Sulon J & Hansen HB 1996 Pregnancies, calves and calf viability after transfer of in vitro produced bovine embryos. Theriogenology 46 527–539.[CrossRef][Web of Science][Medline]
Symonds ME, Budge H, Stephenson T & McMillen IC 2001 Fetal endocrinology and development - manipulation and adaptation to long-term nutritional and environmental challenges. Reproduction 121 853–862.[Abstract]
Szenci O, Beckers JF, Humblot P, Sulon J, Sasser RG, Taverne MAM, Varga J, Baltusen R & Schekk G 1998 Comparison of ultrasonography, bovine pregnancy-specific protein B, and bovine pregnancy-associated glycoprotein-1 tests for pregnancy detection in dairy cows. Theriogenology 50 77–88.[CrossRef][Web of Science][Medline]
Szenci O, Beckers JF, Sulon J, Bevers MM, Borzsonyi L, Fodor L, Kovács F & Taverne MAM 2003 Effect of induction of late embryonic mortality on plasma profiles of pregnancy associated glycoprotein 1 in heifers. Veterinary Journal 165 307–313.[CrossRef][Web of Science][Medline]
Tefera M, Jeanguyot N, Thibier M & Humblot P 2001 Pregnancy-specific protein B (bPSPB) and progesterone monitoring of postpartum dairy cows with placental retention. Journal of the American Veterinary Medical Association 48 331–336.
Vasquez MI, Horta AEM, Marques CC, Sasser RG & Humblot P 1995 Levels of bPSPB throughout single and twin pregnancies after AI or transfer of IVM/IVF cattle embryos. Animal Reproduction Science 38 279–289.[CrossRef][Web of Science]
Vatnick I, Schoknecht PA, Darrigrand R & Bell AW 1991 Growth and metabolism of the placenta after unilateral fetectomy in twin pregnancy ewes. Journal of Developmental Physiology 15 351–356.[Web of Science][Medline]
Wallace CR 1993 Concentration of bovine placental lactogen in dairy and beef cows across gestation. Domestic Animal Endocrinology 10 67–70.[CrossRef][Web of Science][Medline]
Wallace JM, Bourke DA & Aitken RP 1999 Nutrition and fetal growth: paradoxical effects in the overnourished adolescent sheep. Journal of Reproduction and Fertility 54 Suppl. 385–399.
Wooding FBP 1992 The synepitheliochorial placenta of ruminants: binucleate cell fusions and hormone production. Placenta 13 101–113.[Web of Science][Medline]
Wooding FBP, Morgan G, Monaghan S, Hamon M & Heap RB 1996 Functional specialization in the ruminant placenta: evidence of two populations of fetal binucleate cells of different selective synthetic capacity. Placenta 17 75–86.[Web of Science][Medline]
Xie S, Low BG, Nagel RJ, Kramer KK, Anthony RV, Zoli AP, Beckers JF & Roberts RM 1991 Identification of the major pregnancy-specific antigens of cattle and sheep as inactive members of the aspartic proteinase family. PNAS 88 10247–10251.
Xie S, Green J, Beckers JF & Roberts RM 1995 The gene encoding bovine pregnancy-associated glycoprotein-1, an inactive member of the aspartic proteinase family. Gene 159 193–197.[CrossRef][Web of Science][Medline]
Zoli AP, Becker JF, Wouters-Ballman P, Closset J, Falmagne P & Ectors F 1991 Purification and characterization of a bovine pregnancy-associated glycoprotein. Biology of Reproduction 45 1–10.[Abstract]
This article has been cited by other articles:
 |
|
 |
|
  W. J. Weber, C. R. Wallace, L. B. Hansen, H. Chester-Jones, and B. A. Crooker Effects of Genetic Selection for Milk Yield on Somatotropin, Insulin-Like Growth Factor-I, and Placental Lactogen in Holstein Cows J Dairy Sci, July 1, 2007; 90(7): 3314 - 3325. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
P < 0.1.